IP Library Granted Patent US 7,737,179
Granted Patent B2
US 7,737,179 · App. 10/910,095 · Granted Jun 15, 2010

Methods for treatment of dermatological conditions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,737,179
App. No.
10/910,095
Granted
Jun 15, 2010
Kind
B2
Abstract

A method of reducing the appearance of skin conditions associated with loss of skin tightness, skin firmness, or dark circles under the eyes with topical compositions comprising compounds of any of the Formulae I or Ia as described herein, is disclosed.

Claims (4)

1. A for reducing the appearance of skin wrinkles, sagging in the eye area or jowls, frown lines, expression lines, striae, stretch marks, loss of skin elasticity, loss of skin tightness, loss of skin firmness, loss of skin recoil from deformation, loss of collagen and elastic fibers, comprising topically applying to affected skin areas a composition comprising an effective amount of N-(2-hydroxyethyl)-iminodiacetic acid or acceptable salts thereof.

2. The method of claim 1 , comprising administering a composition comprising the effective amount of N-(2-hydroxyethyl)-iminodiacetic acid in admixture with at least one cosmetically acceptable excipient.

3. The method of claim 1 , wherein the treatment is for improving the appearance of loss of skin elasticity, skin tightness or skin firmness.

4. The method of claim 1 , comprising administering a topical composition comprising the effective amount of N-(2-hydroxyethyl)-iminodiacetic acid with at least one additional benefit agent selected from sunscreens, retinoids, antioxidants; hydroxyacids; fatty acids; acceptable non-toxic organic salts of zinc, copper or magnesium, optionally derived from naturally occurring amino acids or from hydroxyalkyl acids; botanical extracts; salicylic acid; benzoyl peroxide; antibiotics; antiandrogens; anti-inflammatory agents; ascorbic acid; vitamins B, tocopherols or tocotrienols; corticosteroids, or mixtures thereof.

Assignments (7)
CORRECTIVE ASSIGNMENT TO CORRECT THE MERGED ENTITY' NEW NAME PREVIOUSLY RECORDED AT REEL: 036041 FRAME: 0605. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER & CHANGE OF NAME. Recorded Jul 21, 2015
From: JOHNSON & JOHNSON CONSUMER COMPANIES, LLC
To: JOHNSON & JOHNSON CONSUMER INC.
Reel/Frame 036143/0449 →
MERGER AND CHANGE OF NAME Recorded Jul 1, 2015
From: JOHNSON & JOHNSON CONSUMER COMPANIES, LLC; JOHNSON & JOHNSON CONSUMER INC.
To: JOHNSON & JOHNSON CONSUMER INC
Reel/Frame 036041/0605 →
MERGER Recorded Jul 1, 2015
From: JOHNSON & JOHNSON CONSUMER COMPANIES, INC.
To: JOHNSON & JOHNSON CONSUMER COMPANIES, LLC
Reel/Frame 036043/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2006
From: GALILEO PHARMACEUTICALS, INC.
To: JOHNSON & JOHNSON CONSUMER COMPANIES, INC.
Reel/Frame 018407/0725 →
CHANGE OF NAME Recorded Aug 31, 2006
From: GALILEO PHARMACEUTICALS, INC.; GALILEO LABORATORIES
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 018195/0409 →
THE NAME OF THE RECEIVING PARTY IS INCORRECT Recorded Aug 29, 2006
From: WANG, BING; BODDUPALLI, SEKHAR; LI, XIANGFENG; MAHMOOD, KHALID; ZHANG,WEI; MILLER, GUY
To: GALILEO LABORATORIES
Reel/Frame 018192/0144 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2004
From: WANG, BING; BODDUPALLI, SEKHAR; LI, XIANFENG; MAHMOOD, KHALID; ZHANG, WEI; MILLER, GUY
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 016062/0610 →